menu search

AMPH / Amphastar Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference

Amphastar Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 12, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, Jacob Liawatidewi, EVP of Corporate Administration, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on April 19th, 2023 at 12:45 pm Eastern Time. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. Read More
Posted: Apr 12 2023, 16:10
Author Name: Accesswire
Views: 101999

AMPH News  

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023

By Accesswire
November 1, 2023

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 1, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results f more_horizontal

Amphastar Pharmaceuticals (AMPH) Rises Yet Lags Behind Market: Some Facts Worth Knowing

By Zacks Investment Research
October 31, 2023

Amphastar Pharmaceuticals (AMPH) Rises Yet Lags Behind Market: Some Facts Worth Knowing

In the most recent trading session, Amphastar Pharmaceuticals (AMPH) closed at $45.27, indicating a +0.2% shift from the previous trading day. more_horizontal

Amphastar Pharmaceuticals (AMPH) Laps the Stock Market: Here's Why

By Zacks Investment Research
October 30, 2023

Amphastar Pharmaceuticals (AMPH) Laps the Stock Market: Here's Why

The latest trading day saw Amphastar Pharmaceuticals (AMPH) settling at $45.19, representing a +1.23% change from its previous close. more_horizontal

Amphastar Pharmaceuticals (AMPH) Rises As Market Takes a Dip: Key Facts

By Zacks Investment Research
October 23, 2023

Amphastar Pharmaceuticals (AMPH) Rises As Market Takes a Dip: Key Facts

In the closing of the recent trading day, Amphastar Pharmaceuticals (AMPH) stood at $44.72, denoting a +0.52% change from the preceding trading day. more_horizontal

Amphastar Pharmaceuticals (AMPH) Laps the Stock Market: Here's Why

By Zacks Investment Research
October 16, 2023

Amphastar Pharmaceuticals (AMPH) Laps the Stock Market: Here's Why

Amphastar Pharmaceuticals (AMPH) closed at $46.47 in the latest trading session, marking a +1.55% move from the prior day. more_horizontal

Amphastar Pharmaceuticals: Great Growth At A High Price

By Seeking Alpha
October 10, 2023

Amphastar Pharmaceuticals: Great Growth At A High Price

Amphastar Pharmaceuticals has implemented aggressive corporate strategies to maximize margins and increase sales, resulting in impressive EBIT and rev more_horizontal

Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year?

By Zacks Investment Research
October 10, 2023

Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year?

Here is how Amphastar Pharmaceuticals (AMPH) and Acadia Pharmaceuticals (ACAD) have performed compared to their sector so far this year. more_horizontal

Amphastar Pharmaceuticals (AMPH) Rises Higher Than Market: Key Facts

By Zacks Investment Research
October 9, 2023

Amphastar Pharmaceuticals (AMPH) Rises Higher Than Market: Key Facts

In the closing of the recent trading day, Amphastar Pharmaceuticals (AMPH) stood at $47.55, denoting a +0.76% change from the preceding trading day. more_horizontal


Search within

Pages Search Results: